Argen X SE ADR
Argen X SE ADR (ARGX) Wheel Strategy
ARGX wheel strategy scan found 187 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 74.9%.
Read more
Running a ARGX wheel strategy lets you generate consistent premium income on Argen X SE ADR while setting your own entry and exit prices on the underlying. Argen X SE ADR's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ARGX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ARGX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ARGX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ARGX wheel from a losing one.
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, Japan, Europe, Middle East, Africa, and China. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, generalized myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, thyroid eye disease, bullous pemphigoid, myositis, primary sjögren's syndrome, post-covid postural orthostatic tachycardia syndrome, membranous nephropathy, lupus nephropathy, anca-associated vasculitis, and antibody mediated rejection; ENHANZE SC; Empasiprubart for multifocal motor neuropath, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome and amyotrophic lateral sclerosis.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ARGX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ARGX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 950.00 | $10.00 | $13.65 | -0.40 | 7 | 69% | 57.0% | 74.9% | 1 |
| Nov 20, 2026 | 940.00 | $6.00 | $9.70 | -0.32 | 7 | 69% | 64.3% | 53.8% | 149 |
| Dec 18, 2026 | 950.00 | $37.90 | $41.65 | -0.43 | 35 | 69% | 52.1% | 45.7% | 332 |
| Dec 18, 2026 | 940.00 | $33.50 | $37.35 | -0.40 | 35 | 69% | 55.4% | 41.4% | 277 |
| Nov 20, 2026 | 930.00 | $3.00 | $6.85 | -0.24 | 7 | 69% | 71.2% | 38.4% | 4 |
| Dec 18, 2026 | 930.00 | $29.60 | $33.45 | -0.37 | 35 | 69% | 58.8% | 37.5% | 5 |
| Jan 15, 2027 | 950.00 | $52.80 | $57.15 | -0.43 | 63 | 69% | 50.8% | 34.9% | 2 |
| Dec 18, 2026 | 920.00 | $25.80 | $29.80 | -0.34 | 35 | 69% | 62.1% | 33.8% | 28 |
| Jan 15, 2027 | 940.00 | $48.10 | $52.35 | -0.40 | 63 | 69% | 53.3% | 32.3% | 2 |
| Dec 18, 2026 | 910.00 | $22.70 | $26.35 | -0.31 | 35 | 69% | 65.3% | 30.2% | 2 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →